# Evogene Ltd. (EVGN)

> Healthcare · IL · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/EVGN/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 681.0K | $ -7.64M | $ -5.07M | $ 2.10M | $ -3.29M |
| 2025 | $ 4.05M | $ -8.69M | $ -14.47M | $ 2.20M | $ -82.0K |
| 2024 | $ 8.56M | $ -17.33M | $ -21.36M | $ 12.87M | $ -1.45M |
| 2023 | $ 6.10M | $ -25.82M | $ -24.18M | $ 11.51M | $ 12.05M |
| 2022 | $ 1.87M | $ -29.76M | $ -27.76M | $ 11.93M | $ 27.93M |
| 2021 | $ 1.11M | $ -33.04M | $ -30.39M | $ 2.67M | $ 53.65M |
| 2020 | $ 1.32M | $ -29.78M | $ -25.73M | $ 2.44M | $ 46.05M |
| 2019 | $ 971.9K | $ -23.38M | $ -23.57M | $ 2.97M | $ 50.14M |
| 2018 | $ 2.31M | $ -27.41M | $ -20.87M | $ 0 | $ 50.05M |
| 2017 | $ 4.55M | $ -28.07M | $ -22.25M | $ 0 | $ 69.38M |
| 2016 | $ 9.00M | $ -26.96M | $ -17.20M | $ 0 | $ 87.29M |
| 2015 | $ 15.63M | $ -24.17M | $ -20.24M | $ 0 | $ 103.75M |
| 2014 | $ 20.50M | $ -20.53M | $ -17.60M | $ 0 | $ 116.08M |
| 2013 | $ 25.00M | $ -12.63M | $ -9.79M | $ 0 | $ 124.75M |
| 2012 | $ 18.58M | $ -4.30M | $ -4.40M | $ 0 | $ 48.26M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -0.64 |
| Liabilities / Eq | -2.33 |
| Current Ratio | 3.57 |

## Other views

- [Metrics](https://sponda.capital/en/EVGN.md)
- [Charts](https://sponda.capital/en/EVGN/charts.md)
- [Compare](https://sponda.capital/en/EVGN/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.